Clinical Trial Update: A 52-Week Study of Bicifadine in Patients With Chronic Neuropathic Pain Associated With Diabetic Peripheral Neuropathy [Phase 2]

View source ↗

Summary

This clinical trial update reports that a 52-week Phase 2 study of Bicifadine in patients with diabetic peripheral neuropathy-associated chronic neuropathic pai…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathy

Drugs mentioned

• Bicifadine (bicifadine)

Snippet

Sponsor: XTL Biopharmaceuticals | Conditions: Chronic Peripheral Neuropathy Pain in Diabetics | Phase 2 | Status: TERMINATED